The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drugs for Schistosomiasis-Global Market Insights and Sales Trends 2025
Synopsis
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
The global Drugs for Schistosomiasis market size is expected to reach US$ 106.8 million by 2029, growing at a CAGR of 3.8% from 2023 to 2029. The market is mainly driven by the significant applications of Drugs for Schistosomiasis in various end use industries. The expanding demands from the S. haematobium, S. mansoni, S. japonicum and S. mekongi, are propelling Drugs for Schistosomiasis market. Praziquantel, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oxamniquine segment is estimated at % CAGR for the next seven-year period.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drugs for Schistosomiasis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drugs for Schistosomiasis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drugs for Schistosomiasis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drugs for Schistosomiasis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drugs for Schistosomiasis covered in this report include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals, etc.
The global Drugs for Schistosomiasis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Global Drugs for Schistosomiasis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drugs for Schistosomiasis market, Segment by Type:
Praziquantel
Oxamniquine
Other
Global Drugs for Schistosomiasis market, by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drugs for Schistosomiasis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drugs for Schistosomiasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
The global Drugs for Schistosomiasis market size is expected to reach US$ 106.8 million by 2029, growing at a CAGR of 3.8% from 2023 to 2029. The market is mainly driven by the significant applications of Drugs for Schistosomiasis in various end use industries. The expanding demands from the S. haematobium, S. mansoni, S. japonicum and S. mekongi, are propelling Drugs for Schistosomiasis market. Praziquantel, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oxamniquine segment is estimated at % CAGR for the next seven-year period.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drugs for Schistosomiasis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drugs for Schistosomiasis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drugs for Schistosomiasis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drugs for Schistosomiasis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drugs for Schistosomiasis covered in this report include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals, etc.
The global Drugs for Schistosomiasis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Global Drugs for Schistosomiasis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drugs for Schistosomiasis market, Segment by Type:
Praziquantel
Oxamniquine
Other
Global Drugs for Schistosomiasis market, by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drugs for Schistosomiasis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drugs for Schistosomiasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Drugs for Schistosomiasis Market Overview
1.1 Drugs for Schistosomiasis Product Overview
1.2 Drugs for Schistosomiasis Market Segment by Type
1.2.1 Praziquantel
1.2.2 Oxamniquine
1.2.3 Other
1.3 Global Drugs for Schistosomiasis Market Size by Type
1.3.1 Global Drugs for Schistosomiasis Market Size Overview by Type (2018-2029)
1.3.2 Global Drugs for Schistosomiasis Historic Market Size Review by Type (2018-2023)
1.3.3 Global Drugs for Schistosomiasis Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Drugs for Schistosomiasis Sales Breakdown by Type (2018-2023)
1.4.2 Europe Drugs for Schistosomiasis Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Drugs for Schistosomiasis Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Drugs for Schistosomiasis Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Drugs for Schistosomiasis Sales Breakdown by Type (2018-2023)
2 Global Drugs for Schistosomiasis Market Competition by Company
2.1 Global Top Players by Drugs for Schistosomiasis Sales (2018-2023)
2.2 Global Top Players by Drugs for Schistosomiasis Revenue (2018-2023)
2.3 Global Top Players by Drugs for Schistosomiasis Price (2018-2023)
2.4 Global Top Manufacturers Drugs for Schistosomiasis Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drugs for Schistosomiasis Market Competitive Situation and Trends
2.5.1 Drugs for Schistosomiasis Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Drugs for Schistosomiasis Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2022)
2.7 Date of Key Manufacturers Enter into Drugs for Schistosomiasis Market
2.8 Key Manufacturers Drugs for Schistosomiasis Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Drugs for Schistosomiasis Status and Outlook by Region
3.1 Global Drugs for Schistosomiasis Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Drugs for Schistosomiasis Historic Market Size by Region
3.2.1 Global Drugs for Schistosomiasis Sales in Volume by Region (2018-2023)
3.2.2 Global Drugs for Schistosomiasis Sales in Value by Region (2018-2023)
3.2.3 Global Drugs for Schistosomiasis Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Drugs for Schistosomiasis Forecasted Market Size by Region
3.3.1 Global Drugs for Schistosomiasis Sales in Volume by Region (2024-2029)
3.3.2 Global Drugs for Schistosomiasis Sales in Value by Region (2024-2029)
3.3.3 Global Drugs for Schistosomiasis Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Drugs for Schistosomiasis by Application
4.1 Drugs for Schistosomiasis Market Segment by Application
4.1.1 S. haematobium
4.1.2 S. mansoni
4.1.3 S. japonicum
4.1.4 S. mekongi
4.1.5 S. intercalatum
4.2 Global Drugs for Schistosomiasis Market Size by Application
4.2.1 Global Drugs for Schistosomiasis Market Size Overview by Application (2018-2029)
4.2.2 Global Drugs for Schistosomiasis Historic Market Size Review by Application (2018-2023)
4.2.3 Global Drugs for Schistosomiasis Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drugs for Schistosomiasis Sales Breakdown by Application (2018-2023)
4.3.2 Europe Drugs for Schistosomiasis Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Drugs for Schistosomiasis Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Drugs for Schistosomiasis Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Drugs for Schistosomiasis Sales Breakdown by Application (2018-2023)
5 North America Drugs for Schistosomiasis by Country
5.1 North America Drugs for Schistosomiasis Historic Market Size by Country
5.1.1 North America Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Drugs for Schistosomiasis Sales in Volume by Country (2018-2023)
5.1.3 North America Drugs for Schistosomiasis Sales in Value by Country (2018-2023)
5.2 North America Drugs for Schistosomiasis Forecasted Market Size by Country
5.2.1 North America Drugs for Schistosomiasis Sales in Volume by Country (2024-2029)
5.2.2 North America Drugs for Schistosomiasis Sales in Value by Country (2024-2029)
6 Europe Drugs for Schistosomiasis by Country
6.1 Europe Drugs for Schistosomiasis Historic Market Size by Country
6.1.1 Europe Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Drugs for Schistosomiasis Sales in Volume by Country (2018-2023)
6.1.3 Europe Drugs for Schistosomiasis Sales in Value by Country (2018-2023)
6.2 Europe Drugs for Schistosomiasis Forecasted Market Size by Country
6.2.1 Europe Drugs for Schistosomiasis Sales in Volume by Country (2024-2029)
6.2.2 Europe Drugs for Schistosomiasis Sales in Value by Country (2024-2029)
7 Asia-Pacific Drugs for Schistosomiasis by Region
7.1 Asia-Pacific Drugs for Schistosomiasis Historic Market Size by Region
7.1.1 Asia-Pacific Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Drugs for Schistosomiasis Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Drugs for Schistosomiasis Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Drugs for Schistosomiasis Forecasted Market Size by Region
7.2.1 Asia-Pacific Drugs for Schistosomiasis Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Drugs for Schistosomiasis Sales in Value by Region (2024-2029)
8 Latin America Drugs for Schistosomiasis by Country
8.1 Latin America Drugs for Schistosomiasis Historic Market Size by Country
8.1.1 Latin America Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Drugs for Schistosomiasis Sales in Volume by Country (2018-2023)
8.1.3 Latin America Drugs for Schistosomiasis Sales in Value by Country (2018-2023)
8.2 Latin America Drugs for Schistosomiasis Forecasted Market Size by Country
8.2.1 Latin America Drugs for Schistosomiasis Sales in Volume by Country (2024-2029)
8.2.2 Latin America Drugs for Schistosomiasis Sales in Value by Country (2024-2029)
9 Middle East and Africa Drugs for Schistosomiasis by Country
9.1 Middle East and Africa Drugs for Schistosomiasis Historic Market Size by Country
9.1.1 Middle East and Africa Drugs for Schistosomiasis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Drugs for Schistosomiasis Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Drugs for Schistosomiasis Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Drugs for Schistosomiasis Forecasted Market Size by Country
9.2.1 Middle East and Africa Drugs for Schistosomiasis Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Drugs for Schistosomiasis Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Shin Poong
10.1.1 Shin Poong Company Information
10.1.2 Shin Poong Introduction and Business Overview
10.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Shin Poong Drugs for Schistosomiasis Products Offered
10.1.5 Shin Poong Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Drugs for Schistosomiasis Products Offered
10.2.5 Merck Recent Development
10.3 Bayer
10.3.1 Bayer Company Information
10.3.2 Bayer Introduction and Business Overview
10.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bayer Drugs for Schistosomiasis Products Offered
10.3.5 Bayer Recent Development
10.4 EIPICO
10.4.1 EIPICO Company Information
10.4.2 EIPICO Introduction and Business Overview
10.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2018-2023)
10.4.4 EIPICO Drugs for Schistosomiasis Products Offered
10.4.5 EIPICO Recent Development
10.5 Chandra Bhagat Pharma
10.5.1 Chandra Bhagat Pharma Company Information
10.5.2 Chandra Bhagat Pharma Introduction and Business Overview
10.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Products Offered
10.5.5 Chandra Bhagat Pharma Recent Development
10.6 Taj Pharmaceuticals
10.6.1 Taj Pharmaceuticals Company Information
10.6.2 Taj Pharmaceuticals Introduction and Business Overview
10.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Products Offered
10.6.5 Taj Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Drugs for Schistosomiasis Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drugs for Schistosomiasis Industrial Chain Analysis
11.4 Drugs for Schistosomiasis Market Dynamics
11.4.1 Drugs for Schistosomiasis Industry Trends
11.4.2 Drugs for Schistosomiasis Market Drivers
11.4.3 Drugs for Schistosomiasis Market Challenges
11.4.4 Drugs for Schistosomiasis Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Drugs for Schistosomiasis Distributors
12.3 Drugs for Schistosomiasis Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
